Biome Makers
Biome Makers is an agricultural technology company that provides biological soil testing and analysis through its BeCrop technology platform, empowering farmers and agricultural stakeholders to recover soil health worldwide. The company operates the largest taxonomic microorganism database with 55 million microorganisms, has served over 60,000 farmers, analyzed more than 200 crop types across 56-plus countries, and…
Funding snapshot
About
Biome Makers is an agricultural technology company that provides biological soil testing and analysis through its BeCrop technology platform, empowering farmers and agricultural stakeholders to recover soil health worldwide. The company operates the largest taxonomic microorganism database with 55 million microorganisms, has served over 60,000 farmers, analyzed more than 200 crop types across 56-plus countries, and maintains over 200 industry collaborations. BeCrop technology offers four products: BeCrop Farm for maximizing acre potential, BeCrop Test for advanced biological soil testing, BeCrop Trials for functional soil analysis, and BeCrop Rate for sustainable land assessment. The platform decodes soil biology data to provide actionable intelligence on yield limitations, disease diagnosis, and nutrient management recommendations. Biome Makers also runs a BeCrop Advisor certification program for soil health management professionals. Founded in 2015 and headquartered in Davis, California, the company has raised $21.2 million through Series B funding from investors including Viking Global Investors, Prosus, Seaya, Illumina, DST Global, and JME Venture Capital.
Business model
Genomics > Applied Genomics > Agrigenomics > Soil Microbiome Analysis,
Crop Tech > Farm Inputs > Seeds > Field Crops > GMO,
Plug and Play Tech Center Batches > Food & Beverage > Batch 2
Founders & team highlights
Serial Founder
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.